Healthcare
Angiex, Inc.
Recorded September 18, 2024
Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ to address the hallmarks of cancer lethality.
Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ to address the hallmarks of cancer lethality.
Caliber Company [NASDAQ: CWD] and PURE Pickleball are building the largest indoor pickleball facility in the world
M6P has developed a breakthrough technology that is driving the development of next generation enzyme replacement therapies.
Repair Bio has developed a cholesterol degrading platform that has the potential to reverse atherosclerosis and many other diseases
How EpiQuest [NASDAQ: EEIQ], is profitingby making a North American higher education accessibleto the world.
How EpiQuest [NASDAQ: EEIQ], is profitingby making a North American higher education accessibleto the world.
Sigyn Therapeutics has developed patented devices that improve the performance of drugs that treat cancer.
Deep sea nodule collection provides higher quality critical minerals with significantly lower environmental impact than traditional mining.
Sigyn Therapeutics has developed patented devices that improve the performance of drugs that treat cancer.
Deep sea nodule collection provides higher quality critical minerals with significantly lower environmental impact than traditional mining.
An anti-inflammation platform that has the potential to treat Parkinson’s, Alzheimer’s, Liver disease, Diabetes, Arthritis and more.
Rally has built an asset-lite, dynamic, intercity transportation network, helping to fill the $5B worth of bus seats that go unsold every year